{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:15:11Z","timestamp":1790626511795,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["Tele10-A4"],"award-info":[{"award-number":["Tele10-A4"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaci.2019.11.043","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:22:37Z","timestamp":1577100157000},"page":"1262-1271.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Treatment with rapamycin can restore regulatory T-cell function in IPEX patients"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-7386","authenticated-orcid":false,"given":"Laura","family":"Passerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Barzaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Curto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sartirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Barera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Albarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Alberto","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bazzigaluppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Lampasona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Zama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Hoenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus G.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Olek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Roncarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Cicalese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-6268","authenticated-orcid":false,"given":"Rosa","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.11.043_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2019.11.043_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib4","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1182\/blood-2009-02-206359","article-title":"Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation","volume":"113","author":"Seidel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.11.043_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13052-014-0068-4","article-title":"Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea","volume":"40","author":"Zama","year":"2014","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaci.2019.11.043_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2005.04.017","article-title":"Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)","volume":"147","author":"Bindl","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2019.11.043_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune\u00ae (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaci.2019.11.043_bib9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.4049\/jimmunol.178.4.2163","article-title":"A role for mammalian target of rapamycin in regulating T cell activation versus anergy","volume":"178","author":"Zheng","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/eji.201041073","article-title":"Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells","volume":"41","author":"Gabrysova","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib11","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib12","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/db08-0138","article-title":"Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells","volume":"57","author":"Monti","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2019.11.043_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cei.12669","article-title":"Oscillatory mTOR inhibition and Treg cell increase in kidney transplantation","volume":"182","author":"Sabbatini","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-016-8591-2","article-title":"An Update on the use of immunomodulators in primary immunodeficiencies","volume":"52","author":"Vignesh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23822\/EurAnnACI.1764-1489.22","article-title":"New therapeutic approach by sirolimus for enteropathy treatment in patients with lrba deficiency","volume":"49","author":"Azizi","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12721","article-title":"What did we learn from CTLA-4 insufficiency on the human immune system?","volume":"287","author":"Mitsuiki","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2019.11.043_bib17","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/eji.201040909","article-title":"Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome","volume":"41","author":"Passerini","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2011.12.009","article-title":"Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome","volume":"38","author":"Barzaghi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2019.11.043_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaci.2011.09.010","article-title":"Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability","volume":"128","author":"Passerini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib20","doi-asserted-by":"crossref","first-page":"e78664","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.11.043_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007320","article-title":"CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer","volume":"5","author":"Passerini","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.11.043_bib22","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db10-1201","article-title":"Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes","volume":"60","author":"Badami","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2019.11.043_bib23","doi-asserted-by":"crossref","first-page":"989434","DOI":"10.1155\/2014\/989434","article-title":"Rapamycin regulates iTreg function through CD39 and Runx1 pathways","volume":"2014","author":"Lu","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2019.11.043_bib24","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1096\/fj.11-193672","article-title":"Naturally occurring regulatory T cells: markers, mechanisms, and manipulation","volume":"26","author":"Schmetterer","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2019.11.043_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ceb.2011.08.006","article-title":"TOR in the immune system","volume":"23","author":"Araki","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jaci.2019.11.043_bib26","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/eji.200838145","article-title":"Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and ROR\u03b3t","volume":"38","author":"Yang","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib27","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1189\/jlb.1207851","article-title":"De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in\u00a0vivo following systemic antigen administration accompanied by blockade of mTOR","volume":"83","author":"Kang","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2019.11.043_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ni.3390","article-title":"Phosphatase PP2A is requisite for the function of regulatory T cells","volume":"17","author":"Apostolidis","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","article-title":"Functional reprogramming of regulatory T cells in the absence of Foxp3","volume":"20","author":"Charbonnier","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.11.043_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.043_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1053\/j.gastro.2011.07.040","article-title":"Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis","volume":"141","author":"Wirtz","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.043_bib33","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.4049\/jimmunol.181.10.6898","article-title":"Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35","volume":"181","author":"Bardel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/eji.200939527","article-title":"Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC","volume":"40","author":"Seyerl","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.11.043_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2011.12.009","article-title":"Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome","volume":"38","author":"Barzaghi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2019.11.043_bib36","doi-asserted-by":"crossref","first-page":"e78664","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.11.043_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.09.010","article-title":"Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability","volume":"128","author":"Passerini","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919325928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919325928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:27:36Z","timestamp":1758792456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919325928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0091674919325928"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.043","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}